Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy

By /

Sumitomo Heavy Industries, Ltd. announced the decision to invest in Alpha Fusion Inc., a developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy.

Scroll to Top